Comparing Functional Outcomes and Safety Profiles of First-Line Aspiration Thrombectomy Versus Stentriever for Acute Basilar Artery Occlusion: Propensity Analysis of the PC-SEARCH Thrombectomy Registry

医学 改良兰金量表 基底动脉 四分位间距 冲程(发动机) 外科 倾向得分匹配 闭塞 内科学 缺血性中风 缺血 机械工程 工程类
作者
A Mierzwa,Sami Al Kasab,Ashley Nelson,Santiago Ortega‐Gutiérrez,Juan Vivanco‐Suarez,Mudassir Farooqui,Ashutosh P. Jadhav,Shashvat M. Desai,Gábor Tóth,Anas Alrohimi,Thanh N. Nguyen,Piers Klein,Mohamad Abdalkader,Hisham Salahuddin,Aditya S. Pandey,Sravanthi Koduri,Niraj Vora,Nameer Aladamat,Khaled M. Gharaibeh,Ehad Afreen
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:54 (10): 2512-2521 被引量:13
标识
DOI:10.1161/strokeaha.123.043579
摘要

BACKGROUND: Aspiration catheters (ASPs) and stentriever thrombectomy devices have comparable safety and efficacy in anterior circulation ischemic strokes. However, there is lack of high-quality comparative data in acute basilar artery occlusions. Our objective is to compare the outcomes and safety of ASPs and stentriever devices in acute basilar artery occlusions. METHODS: This is an analysis of the retrospectively established PC-SEARCH Thrombectomy (Posterior-Circulation Ischemic Stroke Evaluation: Analyzing Radiographic and Intraprocedural Predictors for Mechanical Thrombectomy) registry. Patients were dichotomized based on their first-line thrombectomy device (ASP and stentriever) and associated with their 90-day functional outcomes, intraprocedural metrics, and safety measures. Propensity analysis based on unequal baseline characteristics was performed. Consecutive patients with acute basilar artery occlusions who received mechanical thrombectomy were included from January 2015 to December 2021. Patients received either first-line contact aspiration or stentriever mechanical thrombectomy. Primary clinical and safety outcomes were 90-day functional independence measured by a modified Rankin Scale score of 0 to 3 and symptomatic intracranial hemorrhage, respectively. Secondary outcomes included puncture-recanalization times, first-pass recanalization rates, crossovers to other thrombectomy device, and neurological/hospital complications. RESULTS: Five hundred eighteen patients were included in the registry, and a total of 383 patients were included (mean [SD] age, 65.5 [15] years; 228 [59%] men) in this analysis. Of these, 219 patients were first-line ASP while 164 patients received first-line stentriever devices. Median premorbid modified Rankin Scale was zero and median presenting National Institutes of Health Stroke Scale was 17 (interquartile range, 8–26). The proportion of favorable functional outcome was similar between the 2 techniques before (47.3% versus 42.5%; odds ratio, 1.22 [95% CI, 0.78–1.89]; P =0.38) and after propensity matching (odds ratio, 1.46 [95% CI, 0.85–2.49]; P =0.17). In our propensity-matched cohorts, puncture-recanalization times (18 versus 52 minutes; P <0.01) favored first-line ASP; however, first-pass recanalization rates (43.5% versus 44.5%; P =0.90) were similar between groups. First-line ASP was associated with higher rates of crossover (22% versus 6%; P <0.01), whereas stentriever was associated with higher rates of symptomatic intracranial hemorrhage (9.8% versus 3.4%; P =0.04). CONCLUSIONS: First-line ASP and stentriever methods demonstrated similar functional outcome and recanalization rates. Stentriever methods were associated with higher rates of symptomatic intracranial hemorrhage, whereas ASPs were associated with higher rates of crossover to alternative technique in patients with acute basilar occlusions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
马尼拉完成签到,获得积分10
1秒前
222发布了新的文献求助10
1秒前
CodeCraft应助猫猫侠采纳,获得10
2秒前
lisbattery发布了新的文献求助10
2秒前
3秒前
思源应助科研通管家采纳,获得10
5秒前
老陈关注了科研通微信公众号
5秒前
今后应助科研通管家采纳,获得10
5秒前
ZSY发布了新的文献求助10
5秒前
pluto应助科研通管家采纳,获得50
5秒前
CodeCraft应助科研通管家采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
Orange应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
5秒前
我是老大应助科研通管家采纳,获得10
5秒前
6秒前
徐小徐发布了新的文献求助10
8秒前
追寻怜蕾完成签到,获得积分10
8秒前
liangliang完成签到,获得积分10
9秒前
Hello应助Naturewoman采纳,获得10
10秒前
10秒前
科研小白完成签到,获得积分10
12秒前
12秒前
大模型应助kellyH采纳,获得10
13秒前
快乐三国杀的裘完成签到,获得积分10
13秒前
13秒前
慕青应助小小牛马采纳,获得10
14秒前
15秒前
15秒前
醒醒完成签到 ,获得积分10
15秒前
15秒前
16秒前
大山完成签到,获得积分10
16秒前
17秒前
大个应助怕黑晓亦采纳,获得10
17秒前
17秒前
风q完成签到,获得积分10
17秒前
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
CLSI M100 Performance Standards for Antimicrobial Susceptibility Testing 36th edition 400
Cancer Targets: Novel Therapies and Emerging Research Directions (Part 1) 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6361439
求助须知:如何正确求助?哪些是违规求助? 8175188
关于积分的说明 17221423
捐赠科研通 5416250
什么是DOI,文献DOI怎么找? 2866218
邀请新用户注册赠送积分活动 1843512
关于科研通互助平台的介绍 1691443